The U.S. Large Molecule Drug Substance CDMO Market is poised for significant expansion, supported by technological advancements, increasing biologics demand, and evolving pharmaceutical outsourcing strategies. With a projected CAGR of 7.5% through 2034, the market demonstrates strong growth potential across the biopharmaceutical sector.
The market forecast for 2030 and beyond indicates...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt